SHAVON LAMAR: Open Payments
NPI 1780010421 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$527 in 21 payments from 7 companies in 2025. Trend: 2023 $1,178 · 2024 $88 · 2025 $527
Food & beverage: $527
| Company | Payments | Amount |
|---|---|---|
| MML US, Inc. | 2 | $161 |
| Medtronic, Inc. | 9 | $136 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $99 |
| Valinor Pharma, LLC | 2 | $40 |
| ABBVIE INC. | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Abbott Laboratories | 1 | $20 |
Products named: ReActiv8, JOURNAVX, INCEPTIV, SYNCHROMEDII, MOVANTIK, RELISTOR, SKYRIZI, PROCLAIM.
Industry payments across TX — which companies pay providers there.
